Advances in Middle East Respiratory Syndrome

Middle East respiratory syndrome (MERS), also known as camel flu, is a viral respiratory infection caused by the MERS-coronavirus (MERS-CoV). Symptoms may range from mild to severe, including fever, cough, diarrhea, and shortness of breath. Middle East respiratory syndrome is caused by the newly identified MERS coronavirus(MERS-CoV),a species with single-stranded RNA belonging to the genus betacoronavirus which is distinct from SARS coronavirus and the common-cold coronavirus. Its genomes are phylogenetically classified into two clades, Clades A and B. Early cases of MERS were of Clade A clusters (EMC/2012 and Jordan-N3/2012) while new cases are genetically different in general (Clade B). There has been evidence of limited, but not sustained spread of MERS-CoV from person to person, both in households as well as in health care settings like hospitals. Most transmission has occurred “in the circumstances of close contact with severely ill persons in healthcare or household settings” and there is no evidence of transmission from asymptomatic cases.

 

In the present book, fourteen typical literatures about Middle East respiratory syndrome published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, virology, epidemiology, ect. We hope this book can demonstrate advances in Middle East respiratory syndrome as well as give references to the researchers, students and other related people.

Components of the Book:
  • Chapter 1
    Middle East Respiratory Syndrome Coronavirus: Review of the Current Situation in the World
  • Chapter 2
    Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Origin and Animal Reservoir
  • Chapter 3
    Adaptive Evolution of Bat Dipeptidyl Peptidase 4 (dpp4): Implications for the Origin and Emergence of Middle East Respiratory Syndrome Coronavirus
  • Chapter 4
    Feasibility, Safety, Clinical, and Laboratory Effects of Convalescent Plasma Therapy for Patients with Middle East Respiratory Syndrome Coronavirus Infection: A Study Protocol
  • Chapter 5
    Middle East Respiratory Syndrome Coronavirus Infection: Virus-Host Cell Interactions and Implications on Pathogenesis
  • Chapter 6
    Real-Time Characterizationof Risks of Death Associated with the Middle East Respiratory Syndrome (MERS) in the Republic of Korea, 2015
  • Chapter 7
    Detection of Middle East Respiratory Syndrome Coronavirus Using Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP)
  • Chapter 8
    Treatment Outcomes for Patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) Infection at a Coronavirus Referral Center in the Kingdom of Saudi Arabia
  • Chapter 9
    Presentation and Outcome of Middle East Respiratory Syndrome in Saudi Intensive Care Unit Patients
  • Chapter 10
    Knowledge and Attitude of Healthcare Workers about Middle East Respiratory Syndrome in Multispecialty Hospitals of Qassim, Saudi Arabia
  • Chapter 11
    Impact of Middle East Respiratory Syndrome Coronavirus (MERS‐CoV) on Pregnancy and Perinatal Outcome
  • Chapter 12
    In-Vitro Renal Epithelial Cell Infection Reveals a Viral Kidney Tropism as a Potential Mechanism for Acute Renal Failure during Middle East Respiratory Syndrome (MERS) Coronavirus Infection
  • Chapter 13
    Modeling [18F]-FDG Lymphoid Tissue Kinetics to Characterize Nonhuman Primate Immune Response to Middle East Respiratory Syndrome-Coronavirus Aerosol Challenge
  • Chapter 14
    Unanswered Questions about the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Readership: Students, academics, teachers and other people attending or interested in Middle East Respiratory Syndrome
Jie Cui
Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Biological Sciences and Sydney Medical School, The University of Sydney, Sydney, Australia

Jie Zhou
State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong Special Administrative Region, China

Kazuya Shirato
Laboratory of Acute Respiratory Viral Diseases and Cytokines, Department of Virology III, National Institute of Infectious Disease, Laboratory of Acute Respiratory Viral Diseases and Cytokines, 4-7-1 Gakuen, Musashimurayama,Tokyo, Japan

Haleema Alserehi
Division of Infectious Diseases, Department of Medicine, King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia

Isabella Eckerle
Institute of Virology, University of Bonn Medical Centre, Sigmund-Freud-Strasse 25, Bonn, Germany

Svetlana Chefer
Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top